ArticleData in brief2026
Dataset of illicit drug consumption during and post COVID-19 through wastewater in a city of Chile.
Article in Data in brief, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dataset of illicit drug consumption during and post COVID-19 through wastewater in a city of Chile.Data in brief · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present dataset reports illicit drug consumption estimated through wastewater-based epidemiology (WBE) in San Pedro de la Paz, Biobío Region, Chile. We collected 24 hour flow proportional Influent wastewater samples at the city wastewater treatment plant (WWTP). Sampling during the COVID-19 period was conducted on twelve days between 9 and 29 August 2021. We collected 50 samples divided in two periods i) COVID-19 period (between 9 and 29 August 2021) and ii) Post-COVID-19 (5 September 2022 to 30 August 2023). Samples collected were preserved by adding Sodium metabisulfite (0.5 g/L), and samples were stored at -20 °C until further analysis. Target analytes included benzoylecgonine (cocaine metabolite), 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH, cannabis metabolite), amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA). Sample preparation involved filtration, pH adjustment, and solid-phase extraction, followed by quantitative analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Quality assurance and quality control (QA/QC) followed the best-practice protocols of the Sewage CORe Group Europe (SCORE) network, including isotopically labelled internal standards, matrix-matched calibration, recovery and matrix-effect assessment, and batch-level blanks and continuing calibration verifications. We normalized concentrations using the daily influent flow and estimated population served by the wastewater treatment plant according to the 2024 Chilean CENSUS. Results are reported as milligrams per day per 1000 inhabitants (mg/day/1000 inhabitants), with values below the limit of quantification informed as "NA". We provide the dataset in an excel file containing collection date, location information, population data, and normalized consumption estimates for each target compound. Data are publicly available in the Mendeley Data repository (DOI: 10.17632/vgpr6b99vf.1) and can be reused for methodological comparisons, inter-study analyses, and secondary modeling applications in WBE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.